bioharvest.com - BHST Company profit before taxes, interest and amortization
Stable raw material harvesting at the Israeli bio-complex ensures high profitability for BioHarvest Sciences (BHST). The EBITDA volume visualizes current profit dynamics, where the 0.00 level indicates the parameter's status. Soil-less production in bioreactors guarantees scalability and margin growth. BioHarvest Sciences (BHST) is currently focusing on US expansion, the development of B2B supplies, and the conduct of therapeutic R&D research.
BioHarvest Sciences Inc. (BHST) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio BioHarvest Sciences|BHST - Long-Term Debt to Capital|Short-Term Debt to Equity BioHarvest Sciences, Inc.|BHST - Company Aggregate Debts|Debts to Net Assets BioHarvest Sciences|BHST - Company Long-Term Debt|Short-Term Debt BioHarvest Sciences|Intermediate Coverage Ratio bioharvest.com
- earnings and market ratios statistics:
BHST - Net Profit|Projected Future Earnings BioHarvest Sciences|BHST - Price to Earnings Ratio|Future Price to Earnings Multiple bioharvest.com|BHST - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BioHarvest Sciences|BHST - Operating profit EBITDA|Net earnings per one share for the last twelve months BioHarvest Sciences|BHST - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months bioharvest.com|BHST - Net earnings per share growth this year|Projected earnings per share increase next year BioHarvest Sciences
Summary company analytics:BHST BioHarvest Sciences Inc
To objectively evaluate the issuer, a portfolio manager requires an analysis of the actual operating cash flow before depreciation and interest, which eliminates the impact of accounting adjustments. By tracking changes in EBITDA, the investor can discern the real cash efficiency of the business, which in the case of BioHarvest Sciences (BHST) confirms the high margins of B2B cellular ingredient supplies and the model's ability to generate high-quality free cash flow.
Competitors of BioHarvest Sciences (BHST)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos)|ANI Pharmaceuticals Inc - Profit before payment of interest, taxes and amortization|MannKind Corp. - Operating profit EBITDA|Operating income before deduction of amortization Amphastar Corp AMPH|Pacira BioSciences (PCRX) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization ars-pharma.com (SPRY)|TBPH (Theravance Biopharma, Inc.) - Operating profit EBITDA|AQST: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SCPH|Operating profit EBITDA tectonictx.com (TECX)|Profit before payment of interest, taxes and amortization Tonix Pharmaceuticals TNXP|Income before deduction of interest, taxes and amortization SXTC|EPRX: Operating profit before deduction of amortization|EXOZ: Profit before payment of interest, taxes and amortization|ORMP: Operating profit EBITDA|Profit before interest, taxes and amortization Entera Bio (ENTX)|Profit before payment of interest, taxes and amortization MindWalk Holdings|abvcpharma.com (ABVC) - Operating income before deduction of amortization|Operating profit before deduction of amortization CPIX (Cumberland Pharmaceuticals Inc.)|Company profit before taxes, interest and amortization QNTM|FibroGen Corp - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TELO|RANI - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Synergy CHC Corp SNYR|RLYB: Operating profit EBITDA|Operating profit before deduction of amortization Lexaria Bioscience Corp.|PULM (Pulmatrix Corp) - Operating profit EBITDA|Pheton (PTHL) - Operating income before deduction of amortization|Operating profit EBITDA APM|LYRA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Impact BioMedical IBO|TNFA: Operating profit before amortization|cbdMD Corp - Operating profit EBITDA|PainReform Corp (PRFX) - Operating profit before deduction of amortization|CYTO: Operating profit EBITDA|Profit before interest, taxes and amortization lipella.com (LIPO)|Profit before payment of interest, taxes and amortization OptiNose|Pieris Pharmaceuticals Inc (PIRS) - Operating income before deduction of amortization|Operating profit EBITDA PROC|Profit before payment of interest, taxes and amortization PTPI (Petros Pharma)|Operating profit EBITDA QLI (Qilian International)|Income before deduction of interest, taxes and amortization SLRN|TFFP - Profit before payment of interest, taxes and amortization
